Rossari Biotech Ltd to Hold Board Meeting on April 27, 2026, to Review FY Results
Rossari Biotech Ltd has scheduled its Board of Directors meeting for Monday, April 27, 2026. The meeting is set to address the approval of the company's financial performance for the quarter and the financial year ended March 31, 2026.The primary agenda items for the Board include approving the Audited Financial Statements and Financial Results, both standalone and consolidated, for the period ending March 31, 2026. Additionally, the Board is expected to recommend the payment of a Final Dividend, if applicable, for the Financial Year that concluded on March 31, 2026.
In connection with its financial results, the company also issued an advisory regarding the trading window. The 'Trading Window' for dealing in securities of Rossari Biotech Ltd for all 'Designated Persons and their immediate relatives' will remain closed starting from April 01, 2026. This restriction will continue until 48 hours following the announcement of the Audited Financial Results for the Quarter and Financial Year ended March 31, 2026.
The Board Meeting details and the closure of the trading window are material updates for investors, focusing on the company's financial review and insider trading protocols.
Stock Price Movement
Rossari Biotech Ltd settled Friday at ₹503.90, gaining 5.21% for the session. Throughout the day, shares tested a low of ₹483.50 before climbing to an intraday high of ₹507.05.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.